Skip to main content
Prasanna Alluri, MD, Radiation Oncology, Dallas, TX

PrasannaAlluriMDPhD

Radiation Oncology Dallas, TX

Breast Cancer

Assistant Professor of Radiation Oncology, UT Southwestern Medical Center

Dr. Alluri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alluri's full profile

Already have an account?

  • Office

    5323 Harry Hines Boulevard
    Dallas, TX 75390
    Phone+1 214-645-8525
    Fax+1 214-645-8527

Summary

  • Dr. Alluri’s clinical focus is in treatment of breast cancer with radiation therapy. He sees the entire spectrum of breast cancer patients – from newly diagnosed early stage breast cancer patients seeking curative treatments to metastatic breast cancer patients looking for innovative clinical trials or palliative treatments for symptom relief.
    Dr. Alluri also directs a research laboratory that's focused on understanding the molecular mechanisms of treatment resistance in breast cancer.
  • Prasanna Alluri, M.D., Ph.D.: Radiation Oncology | Radiation Therapy for Cancer

    As a physician and scientist, Prasanna Alluri, M.D., Ph.D., brings a unique combination of skills to his patients and colleagues. His clinical focus is on breas

Education & Training

  • University of Michigan
    University of MichiganResidency, Radiation Oncology, 2014 - 2017
  • University of Michigan Health System
    University of Michigan Health SystemFellowship, Translational Oncology, 2012 - 2014
  • University of Michigan
    University of MichiganResidency, Surgery, 2009 - 2012
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 2009
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolPh.D., Biological Chemistry, 2006
  • Panjab University
    Panjab UniversityMSc, Medicinal Chemistry, 1998
  • Mangalore University
    Mangalore UniversityB.S., Pharmaceutical Sciences, 1996

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2017 - 2025
  • MI State Medical License
    MI State Medical License 2012 - 2019
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Breast Cancer Translational Research Award METAvivor, 2023
  • Top Doctor in Radiation Oncology Castle Connolly, 2022-2023
  • Breast Cancer - Bone Initiative Research Award Charles Pak Family Foundation, 2022
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • "Androgen Receptor (AR) as a mediator and biomarker of radioresistance in triple-negative breast cancer"  
    Speers, C., Zhao, S.G., Chandler, B., Liu, M., Wilder-Romans, K., Olsen, E., Nyati, S., Ritter, C., Alluri, P.G., Kothari, V., Hayes, D.H., Lawrence, T.S., Spratt, D.,..., NPG Breast Cancer, 1/1/2017
  • "BETs Abet Tam-R in ER-Positive Breast Cancer"  
    Alluri, P.G., Asangani, I.A., Chinnaiyan, A.M., Cell Res, 1/1/2014
  • Basal-like and Triple Negative Breast Cancers: Searching for Positives Among Many Negatives  
    Alluri, P.G., Newman, L.A., Surg Oncol Clin N Am, 1/1/2014
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • CDC20 is a therapeutic target in Triple Negative Breast Cancer
    Sharma, J., Nguyen, J., Raicu, I., Udden, S.M.N., Wang, Q., Alluri, P.G., San Antonio Breast Cancer Symposium, San Antonio, TX, 12/6/2018
  • Targeting CDK4/6 inhibitor resistance in breast cancer
    Wang, Q., Udden, S.M.N., Alluri, P.G., Conquer Cancer Foundation Scientific Retreat, Alexandria, VA, 10/10/2018
  • Targeting Estrogen Receptor (ER) mutations for treatment of endocrine therapy resistance in breast cancer
    Alluri, P.G., Larios, J., Malik, R., Rae, J., Hayes, D., Speers, C., Chinnaiyan, A.M., ASTRO (American Society for Radiation Oncology) Annual Meeting, Boston, MA, 9/25/2016
  • Join now to see all

Lectures

  • Modeling treatment resistance in breast cancer: Advanced Center for Treatment, Research & Education in Cancer (ACTREC) 
    Tata Memorial Center, Mumbai, India - 1/11/2019
  • Targeting treatment resistance in breast cancer with BET inhibition. 
    UT Southwestern Medical Center, Dallas, TX - 9/11/2018
  • Bedside to bench approaches to model treatment resistance in breast cancer. 
    Physician Scientist Conference, UT Southwestern Medical Center, Dallas, TX - 9/6/2018
  • Join now to see all

Press Mentions

  • METAvivor Announces Metastatic Breast Cancer Research Awards
    METAvivor Announces Metastatic Breast Cancer Research AwardsJanuary 30th, 2023
  • Drug Shows Promise in Overcoming Endocrine Therapy Resistance in Breast Cancer
    Drug Shows Promise in Overcoming Endocrine Therapy Resistance in Breast CancerNovember 15th, 2022
  • Cary Council Recognizes UT Southwestern Doctors for Promising Research
    Cary Council Recognizes UT Southwestern Doctors for Promising ResearchJanuary 2nd, 2019
  • Join now to see all

Grant Support

  • Metabolic imaging to study radiation-induced cardiac injuryUT Southwestern Department of Radiation Oncology2019–2020
  • Targeting treatment resistance in breast cancerCary Council, Southwestern Medical Foundation2018–2019
  • Targeting Estrogen Receptor mutations for treatment of endocrine therapy-resistant breast cancerConquer Councer Foundation/ Breast Cancer Research Foundation2017–2018
  • Surgical Oncology Training GrantNational Cancer Institute2012–2014
  • An integrated approach towards targeted therapies for prostate cancer and other epithelial cancersAmerican College of Surgeons2012–2013
  • Role of Staf50 in HIV-1 pathogenesisAmerican Medical Association Foundation2006–2007

Committees

  • Member, Resident Selection Committee, Department of Radiation Oncology, UT Southwestern Medical Center 2022 - Present
  • Member, Diversity, Equity and Inclusion Committee, Department of Radiation Oncology, UT Southwestern Medical Center 2022 - Present
  • Member, Clinical and Translational Research Committee, Department of Radiation Oncology, UT Southwestern Medical Center 2020 - Present
  • Member, Breast Center Executive Committee, Harold Simmons Comprehensive Cancer Center 2019 - Present
  • Member, Breast Program Leadership Committee, Committee, Harold Simmons Comprehensive Cancer Center 2019 - Present
  • Member, UT Southwestern Medical School Admissions Committee 2018 - 2021

Professional Memberships